Anaplasma phagocytophilum, DNA PCR
Use
This test is intended to be used as an aid to the diagnosis of human granulocytic anaplasmosis (HGA), a condition formerly known as human granulocytic ehrlichiosis (HGE), caused by the bacterium Anaplasma phagocytophilum. It employs polymerase chain reaction (PCR) methodology to detect the presence of this pathogen’s DNA in blood specimens, providing a crucial tool for timely diagnosis and management of the condition.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics were determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration, which means it should not be used as the sole basis for diagnosis and should be interpreted in combination with clinical findings and other diagnostic information. The test may require additional confirmatory or reflex testing in some instances.
Methodology
PCR-based (PCR)
Biomarkers
Anaplasma phagocytophilum
Microorganism
LOINC Codes
- 30039-2 - A phagocytoph DNA Bld Ql NAA+probe
- 30039-2 - A phagocytoph DNA Bld Ql NAA+probe
Result Turnaround Time
3-4 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
1 mL
Minimum Volume
0.2 mL
Container
Lavender-top (EDTA) tube or yellow-top (ACD) tube
Storage Instructions
Refrigerate.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | Unstable |
Other tests from different labs that may be relevant